Visceral leishmaniasis in India [5]

Lancet

Volumn 356, Issue 9245, 2000, Pages 1933-

  Bryceson, Anthony ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY; MILTEFOSINE; PAROMOMYCIN; SITAMAQUINE;

DEVELOPING COUNTRY; DOSE RESPONSE; DRUG COST; DRUG POTENCY; HEALTH CARE COST; HUMAN; INDIA; LETTER; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

EID: 0034597899     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)73486-3     Document Type: Letter

References (2)

1. Single dose treatment shows effectiveness for Indian visceral leishmaniasis
2. Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony